Sewoon Medical Co. Ltd
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical … Read more
Sewoon Medical Co. Ltd (100700) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.033x
Based on the latest financial reports, Sewoon Medical Co. Ltd (100700) has a cash flow conversion efficiency ratio of 0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.98 Billion) by net assets (₩150.08 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sewoon Medical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Sewoon Medical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sewoon Medical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sewoon Medical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Singapore Shipping Corporation Limited
F:W1M
|
0.034x |
|
ONDE S.A. ZY -02
F:0XF
|
N/A |
|
Intchains Group Limited American Depositary Shares
NASDAQ:ICG
|
-0.020x |
|
CHA Vaccine Institute Co. Ltd.
KQ:261780
|
-0.140x |
|
Teo Seng Capital Bhd
KLSE:7252
|
0.064x |
|
Kencana Energi Lestari
JK:KEEN
|
-0.006x |
|
Virgin Group Acquisition Corp II
NYSE:GROV
|
-0.121x |
|
BICECORP S.A
SN:BICECORP
|
0.214x |
Annual Cash Flow Conversion Efficiency for Sewoon Medical Co. Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Sewoon Medical Co. Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩146.12 Billion | ₩13.19 Billion | 0.090x | -46.16% |
| 2023-12-31 | ₩137.69 Billion | ₩23.08 Billion | 0.168x | +122.18% |
| 2022-12-31 | ₩123.01 Billion | ₩9.28 Billion | 0.075x | -59.90% |
| 2021-12-31 | ₩114.13 Billion | ₩21.47 Billion | 0.188x | -0.36% |
| 2020-12-31 | ₩101.98 Billion | ₩19.25 Billion | 0.189x | +33.34% |
| 2019-12-31 | ₩95.22 Billion | ₩13.48 Billion | 0.142x | +0.25% |
| 2018-12-31 | ₩86.35 Billion | ₩12.19 Billion | 0.141x | +33.38% |
| 2017-12-31 | ₩77.72 Billion | ₩8.23 Billion | 0.106x | +21.89% |
| 2016-12-31 | ₩73.09 Billion | ₩6.35 Billion | 0.087x | +56.05% |
| 2015-12-31 | ₩65.61 Billion | ₩3.65 Billion | 0.056x | -57.37% |
| 2014-12-31 | ₩64.35 Billion | ₩8.40 Billion | 0.131x | -20.28% |
| 2013-12-31 | ₩58.72 Billion | ₩9.62 Billion | 0.164x | +16.78% |
| 2012-12-31 | ₩51.25 Billion | ₩7.19 Billion | 0.140x | +26.92% |
| 2011-12-31 | ₩46.71 Billion | ₩5.16 Billion | 0.111x | -- |